Botulinum neurotoxin-A in a patient with post-stroke spasticity: a neurophysiological study.

Autor:	Fawzi SM; Department of Physiology, College of Medicine, Al-Nahrain University, Baghdad, Iraq., Hamdan FB; Department of Physiology, College of Medicine, Al-Nahrain University, Baghdad, Iraq., Jaafar IF; Department of Dentistry, Al-Esraa University College, Baghdad, Iraq., Gawwam GAASA; Department of Medicine, College of Medicine, Baghdad University, Baghdad, Iraq.
Jazyk:	angličtina
Zdroj:	Folia neuropathologica [Folia Neuropathol] 2023; Vol. 61 (4), pp. 412-418.
DOI:	10.5114/fn.2023.130030
Abstrakt:	Introduction: Post-stroke spasticity (PSS) is a disorder of the sensory-motor control, leading to upper motor neuron lesions manifesting either as intermittent or sustained involuntary activation of muscles. Botulinum neurotoxin-A (BoNT-A) is mostly utilized in a variety of therapeutic indications, and it is effective and safe in the management of focal PSS in the rehabilitation scenario. The study aimed to evaluate the effect of BoNT-A administration on H-reflex of upper and lower limbs following PSS. In addition, the investigation of the association among the degree of spasticity (assessed by the Modified Ashworth Scale [MAS]) and motor neuron pool excitability (assessed by analysing H-reflex excitability) was done. Material and Methods: Fifty patients with a stroke of either sex aged 30 to 60 years presented with either upper or lower limb focal spasticity were studied. BoNT-A was given on two occasions to the gastrocnemius, soleus, biceps brachii muscles and flexor carpi radialis (FCR). H-reflex was documented from the FCR and soleus muscles at baseline and 3-4 weeks post BoNT-A injection. Medical Research Council scale and MAS were used to assess the PSS and muscle strength. Results: H-reflex latency and amplitude, H/M ratio recorded from FCR and soleus muscles were significantly different between pre- and post-management. The MRC scale was significantly increased whereas the MAS was significantly reduced post BoNT-A injection. Conclusions: BoNT-A causes obvious improvement in PSS clinically as assessed by MAS and MRC scale as well as neurophysiologically by H-reflex. A negative correlation between H-reflex latency but not the amplitude or H max /M max ratio and MAS was observed.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu